Symtrend, 6.25 mg, film-coated tablets
Symtrend, 12.5 mg, film-coated tablets
Symtrend, 25 mg, film-coated tablets
Carvedilol
Symtrend belongs to a group of medicines with alpha- and beta-adrenergic blocking activity. Symtrend is used to treat high blood pressure and angina pectoris. Symtrend is also used as an adjunctive treatment in heart failure, improving heart function.
Before starting treatment with Symtrend, discuss it with your doctor.
Symtrend may enhance the effects of alcohol.
If you are pregnant or breastfeeding, or think you may be pregnant, or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.
Pregnancy
Symtrend should only be used during pregnancy if your doctor considers it essential. Therefore, you should always consult your doctor before taking Symtrend during pregnancy.
Breastfeeding
In animal studies during lactation, it was found that Symtrend passes into human milk, so it is not recommended to take the medicine while breastfeeding.
At the beginning of treatment or when treatment is changed, dizziness or fatigue may occur. If you experience dizziness or weakness while taking the tablets, you should avoid driving or operating machinery.
This medicine contains lactose monohydrate and polydextrose. If you have been told that you have an intolerance to some sugars, you should contact your doctor before taking the medicine.
Always take this medicine exactly as your doctor has told you. If you are not sure, ask your doctor or pharmacist.
In case of feeling that the effect of Symtrend is too strong or too weak, consult your doctor or pharmacist.
Swallow the film-coated tablets with a glass of water. The film-coated tablets can be taken with or without food. However, patients with heart failure should take the film-coated tablets with food to reduce the risk of dizziness when standing up quickly.
The recommended dose is 1 tablet of Symtrend 12.5 mg (equivalent to 12.5 mg of carvedilol) for the first two days, and then 2 tablets of Symtrend 12.5 mg (equivalent to 25 mg of carvedilol) once daily. Other strengths of Symtrend are available for this dosing regimen.
The recommended dose is 1 tablet of Symtrend 12.5 mg (equivalent to 12.5 mg of carvedilol) twice daily for two days, and then 2 tablets of Symtrend 12.5 mg (equivalent to 25 mg of carvedilol) twice daily. Other strengths of Symtrend are available for this dosing regimen.
The usual starting dose is half a tablet of Symtrend 6.25 mg (equivalent to 3.125 mg of carvedilol) twice daily for two weeks. The dose may be gradually increased, usually at two-week intervals.
However, it may be necessary to increase or decrease the dose. Your doctor will inform you about the appropriate dosing.
In case of overdose or accidental ingestion by a child, contact your doctor, go to the hospital, or call the emergency services for advice on the risk and further action.
Symptoms of overdose may include feeling of fainting due to excessive lowering of blood pressure, slowing of heart rate, and in severe cases, occasional cardiac arrest. There may be breathing difficulties, bronchospasm, malaise, disturbances of consciousness, and seizures.
If you forget to take a dose (or doses), take the next dose at the usual time. Do not take a double dose to make up for the missed dose.
If you have any further questions on the use of this product, ask your doctor or pharmacist.
Like all medicines, Symtrend can cause side effects, although not everybody gets them.
The frequency of possible side effects is presented in the table below:
Most side effects are dose-dependent and disappear after dose reduction or discontinuation of treatment. Some side effects may occur at the beginning of treatment and disappear spontaneously during continued treatment.
Dizziness, headache, heart failure, low blood pressure, fatigue.
Bronchitis, pneumonia, upper respiratory tract infection, urinary tract infection, anemia, weight gain, increased cholesterol levels, disturbances of glucose control, depression, mood changes, vision disturbances, dry eyes, eye irritation, slow heart rate, edema (swelling in more than one part of the body), fluid overload, dizziness when standing up quickly, cold hands and feet, shortness of breath, pulmonary edema, asthma in susceptible patients, nausea, diarrhea, vomiting, gastrointestinal disorders, abdominal pain, pain in arms or legs, urinary retention, pain. Renal failure and renal impairment in patients with atherosclerosis and/or impaired renal function.
Sleep disturbances, pre-syncopal state, syncope, paresthesia, conduction disorders, angina pectoris, certain skin reactions (e.g., allergic dermatitis, urticaria, pruritus, and skin inflammation), psoriasis, impotence.
Thrombocytopenia, nasal congestion.
Leukopenia, allergic reactions, increased liver enzyme activity (ALT, AST, GGTP), urinary incontinence in women, severe skin reactions (e.g., erythema multiforme, Stevens-Johnson syndrome, toxic epidermal necrolysis).
If you experience any side effects, including any not listed in this leaflet, please tell your doctor or pharmacist.
If you experience any side effects, including any not listed in this leaflet, please tell your doctor or pharmacist. Side effects can be reported directly to:
Department for Monitoring of Adverse Reactions to Medicinal Products, Office for Registration of Medicinal Products, Medical Devices, and Biocidal Products
Aleje Jerozolimskie 181C
02-222 Warsaw
Phone: +48 22 49 21 301
Fax: +48 22 49 21 309
website: https://smz.ezdrowie.gov.pl Side effects can also be reported to the marketing authorization holder.
Very common: | occur in more than 1 in 10 patients |
Common: | occur in less than 1 in 10 but more than 1 in 100 patients |
Uncommon: | occur in less than 1 in 100 but more than 1 in 1000 patients |
Rare: | occur in less than 1 in 1000 but more than 1 in 10,000 patients |
Very rare: | occur in less than 1 in 10,000 patients, including isolated cases |
By reporting side effects, you can help provide more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date which is stated on the carton. The expiry date refers to the last day of that month.
Blisters: Do not store above 30°C.
Store in the original package to protect from light.
HDPE bottles: Do not store above 25°C.
Store in the original package to protect from light.
Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. This will help protect the environment.
The active substance is carvedilol.
One tablet contains 6.25 mg, 12.5 mg, or 25 mg of carvedilol.
The other ingredients are:
Microcrystalline cellulose
Lactose monohydrate
Crospovidone CL
Povidone K 30
Colloidal anhydrous silica
Magnesium stearate
Coating – Opadry II White
YS-22-18096 consisting of:
HPMC 2910/Hypromellose 3cP
HPMC 2910/Hypromellose 6cP
HPMC 2910/Hypromellose 50cP
Titanium dioxide (E 171)
Triethyl citrate
Macrogol 8000
Polydextrose Fcc.
6.25 mg, film-coated tablets: white, oval, with a score line on both sides and the marking "6.25" on one side.
12.5 mg, film-coated tablets: white, oval, with a score line on both sides and the marking "12.5" on one side.
25 mg, film-coated tablets: white, oval, with a score line on both sides and the marking "25" on one side.
The tablets can be divided into two equal parts.
Pack sizes: 30 and 60 film-coated tablets.
Symphar Sp. z o.o.
ul. Koszykowa 65
00-667 Warsaw
Dragenopharm Apotheker Püschl GmbH
Göllstraße 1
84529 Tittmoning
Germany
PL: Symtrend
Date of last revision of the leaflet:January 2021
Need help understanding this medicine or your symptoms? Online doctors can answer your questions and offer guidance.